H34.8332 Tributary (branch) retinal vein occlusion, bilateral, stable

Name of the Condition

• Tributary (branch) retinal vein occlusion, bilateral, stable (ICD-10-CM: H34.8332)

Summary

Tributary (branch) retinal vein occlusion, bilateral, stable refers to blockages in the smaller branches of the retinal vein system affecting both eyes, with no active progression or complications. This condition disrupts blood flow from portions of the retina in each eye, potentially leading to localized vision changes such as blurring or distortion. The "stable" designation indicates the occlusion is not actively worsening, and there is no current macular edema, neovascularization, or other acute complications.

Causes

The condition is usually caused by blood clots or thrombi forming in tributary retinal veins. Underlying factors such as atherosclerosis, inflammation, or vein compression may contribute to the blockage. Systemic conditions like hypertension or hypercoagulability can also play a role in its development. The stability of the condition suggests the initial occlusion has not triggered further vascular changes or complications.

Risk Factors

• Advanced age
• Hypertension
• Diabetes mellitus
• High cholesterol
• Smoking
• Cardiovascular disease
• Glaucoma
• Blood disorders (e.g., hypercoagulability)

Symptoms

• Blurred or distorted vision in both eyes
• Floaters or dark spots in the visual field
• Peripheral vision loss in affected areas
• No sudden worsening of symptoms

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated funduscopy, and imaging studies like optical coherence tomography (OCT) or fluorescein angiography. The "stable" status is confirmed by the absence of active macular edema, neovascularization, or other signs of progression on imaging or clinical assessment.

Treatment Options

Treatment focuses on managing underlying risk factors (e.g., blood pressure, cholesterol) and monitoring for complications. Anti-VEGF injections, laser therapy, or antiplatelet agents may be considered if complications develop, but are not typically required for stable cases. Regular follow-up is essential to detect any changes.

Prognosis and Follow-Up

Prognosis is generally favorable for stable cases, with vision often remaining stable or improving slightly over time. Regular follow-up appointments (e.g., every 3–6 months) are recommended to monitor for signs of progression, such as macular edema or neovascularization, which may require intervention.

Complications

While the condition is stable, complications can still arise, including:

• Macular edema (fluid buildup in the macula)
• Retinal neovascularization (abnormal blood vessel growth)
• Vitreous hemorrhage
• Retinal detachment

Lifestyle & Prevention

• Control blood pressure and blood sugar levels
• Maintain a healthy diet and exercise regularly
• Avoid smoking
• Manage cholesterol levels
• Attend regular eye exams to monitor for changes

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden worsening of vision
• New floaters or flashes of light
• Pain or redness in the eyes
• Any signs of active complications (e.g., blurred vision that progresses rapidly)

Tips for Medical Coders

Use H34.8332 for bilateral tributary (branch) retinal vein occlusion confirmed as stable, with no active macular edema, neovascularization, or other complications. Document the bilateral nature of the occlusion and the absence of progression or acute findings to support the "stable" designation. Ensure clinical notes align with the stable status to justify the code.